Drospirenone And Ethinyl Estradiol Kit
Product Images NDC 31722-934

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Drospirenone And Ethinyl Estradiol (NDC 31722-934). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Drosee28sfoil (Drosee28sfoil)

Kit packaging label for Drospirenone and ethinyl estradiol tablets, 3 mg/0.02 mg, by Camber Pharmaceuticals, Inc. The image shows a calendar-style medication guide with circles for each day of the week (Sunday to Saturday) used to track daily dosage. The bottom part displays a blister card layout with 28 circular placeholders, with a section labeled for placebo tablets. Storage instructions indicate 20° to 25°C (68° to 77°F). The label also includes a barcode and manufacturing information from Cyndea Pharma, Spain.*

FDA Label Image

Droseeblodclot (Droseeblodclot)

A bar chart showing the number of women with a blood clot per 10,000 women years (WY) across four groups: Non-Pregnant Non-COC user, COC-User, Pregnancy, and Postpartum (12 weeks only). The chart presents range values for each category, with Postpartum having the highest range, followed by Pregnancy, COC-User, and Non-Pregnant Non-COC user. A note clarifies that Pregnancy data is based on actual pregnancy duration and model assumptions.*

FDA Label Image

Droseechart (Droseechart)

A diagram illustrating pregnancy rates associated with different birth control methods. The vertical arrow indicates the range from fewer pregnancies (fewer than 1 per 100 women per year) at the top to more pregnancies (85 or more per 100 women per year) at the bottom. Groups of methods are listed in boxes aligned to their relative pregnancy rates, from implants and sterilization at the lowest to no birth control at the highest.*

FDA Label Image

Droseedaylabel (Droseedaylabel)

Label panel for Drospirenone and Ethinyl Estradiol Tablets USP 3 mg/0.02 mg kit from Camber Pharmaceuticals, Inc. It shows a memo strip guide for selecting the appropriate start day of the week for the medication, with days listed in a grid format to assist users in beginning their dosing schedule.*

FDA Label Image

Droseedoseorder (Droseedoseorder)

Blister card packaging for Drospirenone and ethinyl estradiol oral contraceptive kit. The card includes 28 circular pill compartments arranged in four rows, each with directional arrows to indicate the order of dose intake and day labels from Sunday to Saturday at the top row for tracking.*

FDA Label Image

Droseefigure1 (Droseefigure1)

This image is a forest plot showing hazard ratios, rate ratios, and odds ratios from various studies related to a pharmaceutical product. The studies are grouped into categories: Prospective Cohort Studies, Retrospective Cohort Studies, Case-Control Studies, and Non-fatal Idiopathic Cases Only. Each study's point estimate is represented by a solid diamond with horizontal lines indicating confidence intervals, displayed on a logarithmic scale axis ranging from 0.1 to 10.*

FDA Label Image

Droseefigure2 (Droseefigure2)

A horizontal bar chart showing the number of women with blood clots out of 10,000 women years (WY) among different populations: Non-Pregnant Non-COC users (1 to 5 cases), COC users (3 to 9 cases), Pregnancy (5 to 20 cases), and Postpartum (12 weeks only) with the highest range from 40 to 65 cases.*

FDA Label Image

Droseefigure3 (Droseefigure3)

Chemical structure diagrams of the active ingredients Drospirenone and Ethinyl estradiol are shown. Each molecule is labeled with its respective name below the structure, illustrating their chemical compositions.*

FDA Label Image

Drospeeblistercarton1x28 (Drospeeblistercarton1x28)

Packaging label for Drospirenone and Ethinyl Estradiol Tablets, USP, 3 mg/0.02 mg, in a kit containing one blister card of 28 tablets. The label includes manufacturer information (Cyndea Pharma, S.L., Spain), distributor (Camber Pharmaceuticals, Inc., Piscataway, USA), and a barcode. The label also contains dosage information, storage instructions, and a warning that the product is for prescription use only.*

FDA Label Image

Drospeeblistercarton3x28 (Drospeeblistercarton3x28)

Packaging label for Drospirenone and Ethinyl Estradiol Tablets, USP containing 3 mg of drospirenone and 0.02 mg of ethinyl estradiol. The label indicates this is a kit containing 3 blister cards of 28 tablets each. The product is manufactured by Cyndea Pharma, S.L. and distributed by Camber Pharmaceuticals, Inc., Piscataway, USA. It is marked Rx only and includes standard pregnancy prevention information.*

FDA Label Image

Drospeecamlogo1 (Drospeecamlogo1)

FDA Label Image

Drospeecamlogo2 (Drospeecamlogo2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.